The DOI matches its Crossref record.
Vitamin-H Channeled Self-Therapeutic P-gp Inhibitor Curcumin-Derived Nanomicelles for Targeting the Tumor Milieu by pH- and Enzyme-Triggered Hierarchical Disassembly
Abstract
An effective nanocarrier-mediated drug delivery to cancer cells primarily faces limitations like the presence of successive drug delivery barriers, insufficient circulation time, drug leakage, and decreased tumor penetration capacity. With the aim of addressing this paradox, a self-therapeutic, curcumin-derived copolymer was synthesized by conjugation with PEGylated biotin via enzyme- and acid-labile ester and acetal linkages. This copolymer is a prodrug of curcumin and self-assembles into ∼150-200 nm-sized nanomicelles; it is capable of encapsulating doxorubicin (DOX) and hence can be designated as self-therapeutic. pH- and enzyme-responsive linkages in the polymer skeleton assist in its hierarchical disassembly only in the tumor microenvironment. Further, the conjugation of biotin and poly(ethylene glycol) (PEG) imparts features of tumor specificity and improved circulation times to the nanocarrier. The dynamic light scattering (DLS) analysis supports this claim and demonstrates rapid swelling and disruption of micelles under acidic pH. UV-vis spectroscopy provided evidence of an accelerated acetal degradation at pH 4.0 and 5.0. The in vitro release studies revealed a controlled release of DOX under acidic conditions and curcumin release in response to the enzyme. The value of the combination index calculated on HepG2 cells was found to be in vivo evidence on a hepatocellular carcinoma (HCC)-induced nude mice model. An evident decrease in MMP-2, MMP-9, and α-fetoprotein (AF…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hierarchical micelles for curcumin and doxorubicin | pH and enzyme | Biotin-channeled curcumin prodrug micelles with doxorubicin | Stage pH then enzyme response; P-gp inhibition first; doxorubicin release next”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [99]
In the citing paper
“Hierarchical micelles can stage pH then enzyme responses to liberate curcumin for P-gp inhibition and amplify doxorubicin against multidrug-resistant lesions [99].”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [99]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 49
- 10.1039/c4ob00164h · DOI
- 10.1021/acsami.8b21580 · DOI
- 10.1039/c9ob00859d · DOI
- 10.1021/acsanm.8b00338 · DOI
- 10.1021/acsanm.8b02076 · DOI
- 10.1039/c5ra27293a · DOI
- 10.1021/mp300488s · DOI
- 10.1016/j.ejps.2016.12.011 · DOI
- 10.1016/j.msec.2018.04.099 · DOI
- 10.1021/acs.biomac.5b00625 · DOI
- 10.1021/acsanm.0c00410 · DOI
- 10.1021/acsabm.9b01070 · DOI
- 10.1039/c7ra03579a · DOI
- 10.1021/mp900021q · DOI
- 10.1021/acs.bioconjchem.8b00119 · DOI
- 10.1021/bc900422j · DOI
- 10.1016/j.msec.2020.111527 · DOI
- 10.1021/nn101670k · DOI
- 10.1021/acs.langmuir.0c00562 · DOI
- 10.3390/md16110439 · DOI
- 10.1016/j.ijbiomac.2020.01.222 · DOI
- 10.1166/jbn.2017.2407 · DOI
- 10.1039/d0ra03467c · DOI
- 10.1021/am402840f · DOI
- 10.1039/c5ra22463b · DOI
- 10.1038/s41598-018-19325-x · DOI
- 10.1039/c4md00196f · DOI
- 10.1021/acs.molpharmaceut.0c00623 · DOI
- 10.1038/srep46057 · DOI
- 10.3109/10717544.2014.990651 · DOI
- 10.1016/j.jddst.2019.101206 · DOI
- 10.1038/srep21459 · DOI
- 10.1016/j.ejmech.2020.112331 · DOI
- 10.1016/j.ejmech.2008.04.021 · DOI
- 10.1039/c5cc03003j · DOI
- 10.1021/acsapm.1c01393 · DOI
- 10.1039/p19730002379 · DOI
- 10.1039/d1nr02065j · DOI
- 10.1039/c7cp05303g · DOI
- 10.1021/bm401098w · DOI
- 10.1039/c4ra15696j · DOI
- 10.1021/bc049853x · DOI
- 10.1021/acs.biomac.7b00317 · DOI
- 10.1021/acsami.7b01120 · DOI
- 10.1016/j.ajps.2019.06.003 · DOI
- 10.1021/acs.biomac.8b00833 · DOI
- 10.1016/j.carbpol.2020.116751 · DOI
- 10.1016/j.jconrel.2017.01.034.Matrix-metalloproteinases · DOI
- 10.1021/nl052396o · DOI
Cited by
Sorted by citations
Sheng, J., Yuan, W., Zhang, M., Chen, Z., Qi, Y., Zhao, Y., & Zhang, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04028-7 · Cited by 35
Metadata
- Authors
- Das, M., Joshi, A., Devkar, R., Seshadri, S., & Thakore, S.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-01-11
- Volume
- 33
- Issue
- 2
- Pages
- 369-385
- ISSN
- 1043-1802
- 1520-4812
- Cited by
- 27
- References
- 0
- Language
- en
- Licence
- Funders
- Solvay Research and Innovation Center (GCU-4/S.R.F./93/#10154/444)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review